glutathione disulfide has been researched along with Chronic Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bar, A; Blat, A; Briones, A; Bulat, K; Chlopicki, S; Grosicki, M; Kij, A; Kubisiak, A; Marzec, KM; Matyjaszczyk-Gwarda, K; Mohaissen, T; Proniewski, B; Rodrigues-Diez, R; Sternak, M; Targosz-Korecka, M; Tworzydlo, A; Wajda, A; Wojnar-Lason, K | 1 |
| Aleksandrova, LN; Kovalenko, AL; Petrov, AIu; Romantsov, MG; Sukhanov, DS | 1 |
| Aveleira, CA; Cavadas, C; Domingues, MR; Domingues, P; Faria, R; Maciel, E; Melo, T; Oliveira, MM; Peixoto, F; Santana, MM; Santinha, D; Simões, C | 1 |
| Bhadauria, S; Flora, SJ; Pachauri, V; Yadav, A | 1 |
| Bardají, A; Compte, T; García, C; Giralt, M; Gutierrez, C; Marcas, L; Martinez-Vea, A; Nogues, R; Peralta, C; Romeu, M | 1 |
| Art, T; Bougnet, V; Degand, G; Fiévez, L; Génicot, B; Kirschvink, N; Lekeux, P; Lindsey, P; Marlin, D; Roberts, C; Smith, N | 1 |
| Ibrahim, K; Kingsnorth, AJ; Larvin, M; McMahon, MJ; Nanny, C; O'Reilly, D; Rahman, SH | 1 |
| Bergamini, S; Boraldi, F; Ceccarelli, D; De Vincenzi Paolinelli, C; Garcia-Fernandez, MI; Gheduzzi, D; Muscatello, U; Pasquali-Ronchetti, I; Quaglino, D; Tiozzo, R | 1 |
| Husain, K; Lalla, J; Mejia, J | 1 |
| Day, BJ; Fulton, R; Huang, J; Liang, LP; Patel, M | 1 |
| Choi, YB; Kim, JS; Kim, YI; Lee, KS; Yun, I | 1 |
| Burra, P; Cardin, R; Cecchetto, A; De Maria, N; Della Libera, G; Farinati, F; Floreani, A; Lecis, E; Marafin, C; Naccarato, R | 1 |
| Aw, TY; LeGrand, TS | 1 |
| Lang, CA; Liu, MC; Mastropaolo, W; Mills, BJ | 1 |
1 review(s) available for glutathione disulfide and Chronic Disease
| Article | Year |
|---|---|
[Pathogenetic correction of metabolic disturbances in chronic liver affections].
Topics: Apoptosis; Chronic Disease; Drug Combinations; Flavin Mononucleotide; Glutathione Disulfide; Hepatitis C, Chronic; Humans; Inosine Diphosphate; Lipid Peroxidation; Liver Diseases; Niacinamide; Protective Agents; Succinates | 2012 |
13 other study(ies) available for glutathione disulfide and Chronic Disease
| Article | Year |
|---|---|
Temporal relationship between systemic endothelial dysfunction and alterations in erythrocyte function in a murine model of chronic heart failure.
Topics: Acetylcholine; Animals; Arginase; Chronic Disease; Disease Models, Animal; Eicosanoids; Endothelium, Vascular; Erythrocytes; Glutathione Disulfide; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Mice; Mice, Transgenic; Nitric Oxide; Superoxides; Vascular Diseases; Vasodilation | 2022 |
Alterations in phospholipidomic profile in the brain of mouse model of depression induced by chronic unpredictable stress.
Topics: Animals; Brain; Cardiolipins; Catalase; Chronic Disease; Depressive Disorder; Disease Models, Animal; Glutathione; Glutathione Disulfide; Glutathione Reductase; Male; Mice, Inbred C57BL; Myocardium; Oxidation-Reduction; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phospholipids; Stress, Psychological; Superoxide Dismutase; Uncertainty | 2014 |
Monoisoamyl 2, 3-dimercaptosuccinic acid (MiADMSA) demonstrates higher efficacy by oral route in reversing arsenic toxicity: a pharmacokinetic approach.
Topics: Administration, Oral; Animals; Arsenic; Arsenic Poisoning; Chelating Agents; Chronic Disease; Copper; Dose-Response Relationship, Drug; Glutathione; Glutathione Disulfide; Kidney; Liver; Liver Function Tests; Male; Oxidative Stress; Rats; Rats, Wistar; Succimer; Zinc | 2012 |
Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease.
Topics: Aged; Anemia; Biomarkers; Blood Pressure; Chi-Square Distribution; Chronic Disease; Erythropoietin; Female; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Hematinics; Hemoglobins; Humans; Hypertrophy, Left Ventricular; Kidney Diseases; Lipoproteins, LDL; Logistic Models; Male; Middle Aged; Multivariate Analysis; Oxidative Stress; Recombinant Proteins; Time Factors; Treatment Outcome; Ultrasonography | 2012 |
Effect of chronic airway inflammation and exercise on pulmonary and systemic antioxidant status of healthy and heaves-affected horses.
Topics: Animals; Bronchoalveolar Lavage Fluid; Chronic Disease; Dinoprost; F2-Isoprostanes; Glutathione; Glutathione Disulfide; Horse Diseases; Horses; Inflammation; Lung; Neutrophils; Oxidation-Reduction; Physical Conditioning, Animal; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Uric Acid | 2002 |
Genetic polymorphisms of GSTT1, GSTM1, GSTP1, MnSOD, and catalase in nonhereditary chronic pancreatitis: evidence of xenobiotic stress and impaired antioxidant capacity.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Chronic Disease; Colorimetry; Female; Gene Frequency; Genotype; Glutathione; Glutathione Disulfide; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Middle Aged; Pancreatitis; Polymorphism, Genetic; Superoxide Dismutase | 2005 |
Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations.
Topics: Adenine Nucleotides; Adult; Antioxidants; Biomarkers; Cells, Cultured; Chronic Disease; Female; Fibroblasts; Glutathione; Glutathione Disulfide; Humans; Hydrogen Peroxide; Malondialdehyde; Membrane Potentials; Middle Aged; Mitochondria; Multidrug Resistance-Associated Proteins; Oxidative Stress; Pseudoxanthoma Elasticum; Skin; Superoxide Dismutase | 2006 |
Physiological basis for effect of physical conditioning on chronic ethanol-induced hypertension in a rat model.
Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Chronic Disease; Disease Models, Animal; Ethanol; Glutathione Disulfide; Heart Rate; Hypertension; Male; Malondialdehyde; NADPH Oxidases; Nitric Oxide; Oxidation-Reduction; Physical Conditioning, Animal; Rats; Rats, Inbred F344 | 2006 |
An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo.
Topics: Administration, Oral; Animals; Blood-Brain Barrier; Chronic Disease; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Glutathione; Glutathione Disulfide; Half-Life; Injections, Subcutaneous; Male; Metalloporphyrins; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Parkinson Disease | 2007 |
Ramipril protects from free radical induced white matter damage in chronic hypoperfusion in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Brain Injuries; Brain Ischemia; Chronic Disease; Disease Models, Animal; Free Radicals; Glutathione; Glutathione Disulfide; Malondialdehyde; Neuroglia; Ramipril; Rats; Rats, Sprague-Dawley | 2008 |
Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis.
Topics: Adult; Aged; Chronic Disease; Female; Ferritins; Glutathione; Glutathione Disulfide; Hepacivirus; Hepatitis Antibodies; Hepatitis C; Hepatitis C Antibodies; Humans; Iron; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Sex Characteristics | 1995 |
Chronic hypoxia and glutathione-dependent detoxication in rat small intestine.
Topics: Animals; Chronic Disease; Disulfides; Glutathione; Glutathione Disulfide; Homeostasis; Hypoxia; Inactivation, Metabolic; Intestinal Mucosa; Intestine, Small; Intestines; Male; Proteins; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds | 1996 |
Blood glutathione decreases in chronic diseases.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Chronic Disease; Female; Glutathione Disulfide; Humans; Male; Middle Aged; Risk Factors | 2000 |